Found 6 matching trials
Eliminating Breast Surgery for Breast Cancer Patients With Clinical Complete Response to Neoadjuvant Systemic Therapy
PHASE2Phase II multicenter prospective study on the safety of eliminating surgery...
Location
Tianjin medical university cancer institute and hospital
Clinical Study of Camrelizumab Combined With TCb Versus TCb in Neoadjuvant Treatment of Triple-negative Breast Cancer
PHASE2Triple-negative breast cancer (TNBC) is a special subtype of breast cancer ...
Location
Henan cancer hospital
SHR-A2102 Combined With Adebrelimab as Neoadjuvant Therapy for Early Triple-Negative Breast Cancer
PHASE2This is a prospective, open-label, multicenter Phase II study evaluating th...
Location
Multiple Locations
TCb vs EC-T in High Risk ER+/HER2- Breast Cancer
PHASE3This study will evaluate the efficacy and safety of docetaxel plus carbopla...
Location
Breast cancer institute of Fudan University Cancer Hospital
National Surgical Adjuvant Study of Breast Cancer(N-SAS BC) 07 [RESPECT]
PHASE3To investigate clinical positioning between trastuzumab (Herceptin) monothe...
Location
Aichi Cancer Center Hospital
Predictors of Response to Neoadjuvant Docetaxel-Carboplatin Chemotherapy for Patients With Stage II and III Triple Negative Breast Cancer
N/ANeoadjuvant (preoperative) chemotherapy is an interesting research tool whi...
Location
Hospital Universitario Gregorio Marañon